A small Chinese study using weekly cone beam CT found that the uterus shrank by over 52 percent during chemoradiotherapy in ...

Gift of Life’s ovarian cancer awareness initiatives are rooted in the legacy of Julie Richardson Procter, a Southeast Texas ...

A new review reveals how the long non-coding RNA MIR99AHG acts as a multifunctional host gene and regulatory hub whose ...

Treatment with Rina-S® 120 mg/m² every three weeks demonstrated a clinically meaningful objective response rate (ORR) and durable median duration of response (mDOR) in patients with platinum-resistant ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study ...

Obesity and sedentary behaviour can alter hormonal, metabolic and inflammatory processes in the body, contributing to the ...

Ubamatamab redirects T cells via CD3 engagement to MUC16-expressing tumor cells, leveraging uniformly high MUC16 expression in LGSOC and enabling responses without molecular preselection. At 800 mg ...

This article is authored by Dr Kanika Batra Modi, director and clinical lead, gynae-oncology, Max Saket Hospital, New Delhi.

Cancer is generally diagnosed later in life, but new research shows several types of cancer are becoming more common among younger adults, including uterine cancer. Researchers at the National ...

A woman in her 20s who visited a hospital for abdominal pain, bloating and abnormal bleeding was initially told she had ...

Intraoperative fluorescence imaging holds great promise for achieving complete cytoreduction in ovarian cancer, but its ...

Women shouldn't ignore sudden changes in their periods, bleeding after menopause, persistent bloating, abdominal pain, or ...